CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 14 enrolled
Drug / intervention
contrast echocardiographyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04336995
NCT04336995Phase 4Completed
CompareCT.gov

Echocardiographic Assessment of Pulmonary Transit Time Following Exercise

Vanderbilt University Medical Center·interventional·Posted Apr 7, 2020·Updated Apr 9, 2024

In Brief

A Phase 4 clinical trial evaluating contrast echocardiography for Heart Failure, Diastolic. Completed, enrolled 14 participants across 1 site.

Detailed Summary

The study seeks to measure pulmonary transit time via contrast-echocardiography before and after exercise.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Diastolic
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
202120222023202420252026
First PostedApr 7, 2020
Enrollment StartAug 27, 2020
Primary CompletionAug 25, 2021
Study CompletionMar 1, 2024
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 6.2 years ago

Interventions

contrast echocardiographyother

giving echocardiographic contrast and taking echocardiographic images before and after exercise